Responses
Immunotherapy biomarkers
Original research
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
Compose a Response to This Article
Other responses
No responses have been published for this article.